<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">36438042</PMID><DateRevised><Year>2023</Year><Month>11</Month><Day>02</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2296-858X</ISSN><JournalIssue CitedMedium="Print"><Volume>9</Volume><PubDate><Year>2022</Year></PubDate></JournalIssue><Title>Frontiers in medicine</Title><ISOAbbreviation>Front Med (Lausanne)</ISOAbbreviation></Journal><ArticleTitle>Hospital admission and vaccination as predictive factors of long COVID-19 symptoms.</ArticleTitle><Pagination><StartPage>1016013</StartPage><MedlinePgn>1016013</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1016013</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fmed.2022.1016013</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Since the beginning of the COVID-19 pandemic, a great variability of symptoms that affect all organs and systems of the body has been identified in patients with SARS-CoV-2 infection; this symptomatology can sometimes persist over time, giving rise to the so-called long COVID or post-COVID. The aim of this study is to delve into the clinical characterization of these patients, as well as to take into account the influence of factors such as hospitalization, admission to ICU, history of pneumonia, or vaccination status on the persistence of symptoms.</AbstractText><AbstractText Label="MATERIAL AND METHODS" NlmCategory="UNASSIGNED">An observational, descriptive, multicenter, and retrospective study was designed with a series of cases of people who presented long COVID, which includes univariate, bivariate, and multivariate analyses. Data were obtained from an online <i>ad hoc</i> questionnaire, and statistical analysis was performed using SPSS Software Version 25 (IBM-Inc., Chicago, IL, USA).</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">Hospitalization, ICU admission, history of pneumonia, and vaccination were predictive factors (positive or negative) for the following long-COVID symptoms: headache, menstrual disorders, joint pain, cough, chills, nasal congestion, back pain, abdominal pain, weight loss, eye discomfort, facial erythema, itching, tremors, dizziness, seizures, sleeping difficulty, dry eyes, palpitations, fatigue, paresthesia, dyspnea, aphonia, chest pain, high blood pressure, vomiting, memory loss, brain fog, hypothermia, low blood pressure, sputum or phlegm, lack of concentration, hair loss, and erectile dysfunction.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">This study provides evidence on the clinical characterization of patients suffering from long COVID in order to offer them the most appropriate treatments.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 Romero-Rodr&#xed;guez, P&#xe9;rula-de Torres, Castro-Jim&#xe9;nez, Gonz&#xe1;lez-Lama, Jim&#xe9;nez-Garc&#xed;a, Gonz&#xe1;lez-Bernal, Gonz&#xe1;lez-Santos, V&#xe9;lez-Santamar&#xed;a, S&#xe1;nchez-Gonz&#xe1;lez and Santamar&#xed;a-Pel&#xe1;ez.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Romero-Rodr&#xed;guez</LastName><ForeName>Esperanza</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Maimonides Biomedical Research Institute of Cordoba (IMIBIC), Reina Sofia University Hospital, University of Cordoba, Cordoba, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Multiprofessional Teaching Unit of Family and Community Care, C&#xf3;rdoba and Guadalquivir Health District, C&#xf3;rdoba, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>C&#xf3;rdoba and Guadalquivir Health District, C&#xf3;rdoba, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>P&#xe9;rula-de Torres</LastName><ForeName>Luis &#xc1;ngel</ForeName><Initials>L&#xc1;</Initials><AffiliationInfo><Affiliation>Maimonides Biomedical Research Institute of Cordoba (IMIBIC), Reina Sofia University Hospital, University of Cordoba, Cordoba, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Multiprofessional Teaching Unit of Family and Community Care, C&#xf3;rdoba and Guadalquivir Health District, C&#xf3;rdoba, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Castro-Jim&#xe9;nez</LastName><ForeName>Rafael</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Maimonides Biomedical Research Institute of Cordoba (IMIBIC), Reina Sofia University Hospital, University of Cordoba, Cordoba, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Reina Sof&#xed;a University Hospital, C&#xf3;rdoba, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gonz&#xe1;lez-Lama</LastName><ForeName>Jes&#xfa;s</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Maimonides Biomedical Research Institute of Cordoba (IMIBIC), Reina Sofia University Hospital, University of Cordoba, Cordoba, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Health Center "Matrona Antonia Mesa Fern&#xe1;ndez", Cabra Clinical Management Unit, AGS Sur de C&#xf3;rdoba, C&#xf3;rdoba, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jim&#xe9;nez-Garc&#xed;a</LastName><ForeName>Celia</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Maimonides Biomedical Research Institute of Cordoba (IMIBIC), Reina Sofia University Hospital, University of Cordoba, Cordoba, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>C&#xf3;rdoba and Guadalquivir Health District, C&#xf3;rdoba, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gonz&#xe1;lez-Bernal</LastName><ForeName>Jer&#xf3;nimo J</ForeName><Initials>JJ</Initials><AffiliationInfo><Affiliation>Department of Health Sciences, University of Burgos, Burgos, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gonz&#xe1;lez-Santos</LastName><ForeName>Josefa</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Health Sciences, University of Burgos, Burgos, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>V&#xe9;lez-Santamar&#xed;a</LastName><ForeName>Rodrigo</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Health Sciences, University of Burgos, Burgos, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>S&#xe1;nchez-Gonz&#xe1;lez</LastName><ForeName>Esteban</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Medicine, Central University of Catalonia, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Santamar&#xed;a-Pel&#xe1;ez</LastName><ForeName>Mirian</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Health Sciences, University of Burgos, Burgos, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>11</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Med (Lausanne)</MedlineTA><NlmUniqueID>101648047</NlmUniqueID><ISSNLinking>2296-858X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">admission</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">persistent COVID</Keyword><Keyword MajorTopicYN="N">post-COVID</Keyword><Keyword MajorTopicYN="N">risk factor</Keyword><Keyword MajorTopicYN="N">symptoms</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>8</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>10</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>11</Month><Day>28</Day><Hour>4</Hour><Minute>9</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>11</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>11</Month><Day>29</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>11</Month><Day>11</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36438042</ArticleId><ArticleId IdType="pmc">PMC9691755</ArticleId><ArticleId IdType="doi">10.3389/fmed.2022.1016013</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ministerio de Salud . Informaci&#xf3;n cient&#xed;fico-t&#xe9;cnica. Enfermedad por coronavirus, COVID-19. Inf cient&#xed;fico-t&#xe9;cnico enferm por coronavirus, COVID-19 (2021). Available online at: https://www.sanidad.gob.es/profesionales/saludPublica/ccayes/alertasActual/nCov/documentos/ITCoronavirus.pdf (Consultado el 25 de julio de 2021).</Citation></Reference><Reference><Citation>Crook H, Raza S, Nowell J, Young M, Edison P. Long covid: mecanismos, factores de riesgo y manejo. BMJ. (2021) 374:1648. 10.1136/bmj.n1648</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n1648</ArticleId><ArticleId IdType="pubmed">34312178</ArticleId></ArticleIdList></Reference><Reference><Citation>Organizaci&#xf3;n Mundial de la Salud . Enfermedad por coronavirus (COVID-19). Coronavirus Dis (COVID-19) (2021). Available online at: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/question-and-answers-hub/q-a-detail/coronavirus-disease-covid-19 (Consultado el 25 de julio de 2021).</Citation></Reference><Reference><Citation>Mart&#xed;nez IP, P&#xe9;rula de Torres LA, Lama JG, Garc&#xed;a CJ, Montero RS, Garrido FR. Caracter&#xed;sticas cl&#xed;nico-epidemiol&#xf3;gicas de la infecci&#xf3;n por el virus SARS-CoV-2 en m&#xe9;dicos de familia: un estudio de casos y controles. Aten Primary. (2021) 53:101956. 10.1016/j.aprim.2020.12.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.aprim.2020.12.001</ArticleId><ArticleId IdType="pmc">PMC7746083</ArticleId><ArticleId IdType="pubmed">33592533</ArticleId></ArticleIdList></Reference><Reference><Citation>P&#xe9;rula de Torres L&#xc1;, Gonz&#xe1;lez-Lama J, Garc&#xed;a CJ, Montero RS, Garrido FR, L&#xf3;pez YO, et al. . Frecuencia y validez predictiva de la disfunci&#xf3;n olfativa y gustativa en pacientes con infecci&#xf3;n por SARS-CoV-2. Med Clinic. (2021) 156:595&#x2013;601. 10.1016/j.medcli.2020.12.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.medcli.2020.12.015</ArticleId><ArticleId IdType="pmc">PMC7843111</ArticleId><ArticleId IdType="pubmed">33775400</ArticleId></ArticleIdList></Reference><Reference><Citation>Guan W, Ni Z, Hu Y, Liang W, Ou C, He J, et al. . Caracter&#xed;sticas cl&#xed;nicas de la enfermedad por coronavirus 2019 en China. N Engl J Med. (2020) 382:1708&#x2013;20. 10.1056/NEJMoa2002032</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2002032</ArticleId><ArticleId IdType="pmc">PMC7092819</ArticleId><ArticleId IdType="pubmed">32109013</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Z, McGoogan JM. Caracter&#xed;sticas y lecciones importantes del brote de la enfermedad por coronavirus 2019 (COVID-19) en China: resumen de un informe de 72 314 casos del Centro Chino para el Control y la Prevenci&#xf3;n de Enfermedades. jama. (2020) 323:1239&#x2013;42. 10.1001/jama.2020.2648</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.2648</ArticleId><ArticleId IdType="pubmed">32091533</ArticleId></ArticleIdList></Reference><Reference><Citation>Afecciones persistentes al COVID-19 y afecciones posteriores al COVID-19 | CDC (n.d). Available online at: https://espanol.cdc.gov/coronavirus/2019-ncov/long-term-effects/index.html</Citation></Reference><Reference><Citation>Soriano JB, Murthy S, Marshall JC, Relan P, Diaz JV, Grupo WHOCCDW. Una definici&#xf3;n de caso cl&#xed;nico de condici&#xf3;n post-COVID-19 por un consenso de Delphi. Lancet Infect Dis. (2021) 22:e102&#x2013;7. 10.1016/S1473-3099(21)00703-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00703-9</ArticleId><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu&#xed;a r&#xe1;pida COVID-19: manejo de los efectos a largo plazo de COVID-19 - NICE, RCGP y SIGN (2022). Available online at: https://www.nice.org.uk/guidance/ng188/resources/covid19-rapid-guideline-managing-the-longterm-effects-of-covid19-pdf-51035515742</Citation></Reference><Reference><Citation>Gu&#xed;a Cl&#xed;nica para la atenci&#xf3;n al paciente Long COVID/CVID persistente. Available online at: https://www.semg.es/index.php/consensos-guias-y-protocolos/363-guia-clinica-para-la-atencion-al-paciente-long-covid-covid-persistente</Citation></Reference><Reference><Citation>Bliddal S, Banasik K, Pedersen OB, Nissen J, Cantwell L, Schwinn M, et al. . S&#xed;ntomas agudos y persistentes en pacientes covid-19 no hospitalizados confirmados por PCR. Sci Rep. (2021) 11:1&#x2013;11. 10.1038/s41598-021-92045-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-92045-x</ArticleId><ArticleId IdType="pmc">PMC7791137</ArticleId><ArticleId IdType="pubmed">33414495</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre CH, Murray B, Varsavsky T, Graham MS, Penfold RS, Bowyer RC, et al. . Atributos y predictores de COVID largo. Nat Med. (2021) 27:626&#x2013;31. 10.1038/s41591-021-01292-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01292-y</ArticleId><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Augustin M, Schommers P, Stecher M, Dewald F, Gieselmann L, Gruell H, et al. . S&#xed;ndrome post-COVID en pacientes no hospitalizados con COVID-19: un estudio de cohorte prospectivo longitudinal. Lancet Reg Heal. (2021) 6:100122. 10.1016/j.lanepe.2021.100122</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanepe.2021.100122</ArticleId><ArticleId IdType="pmc">PMC8129613</ArticleId><ArticleId IdType="pubmed">34027514</ArticleId></ArticleIdList></Reference><Reference><Citation>Sociedad Espa&#xf1;ola de M&#xe9;dicos Generales y de Familia . Encuesta PERSISTENTE COVID-19. Encuesta COVID-19 persistente. Available online at: https://www.colfisioaragon.org/ficheros/ResultadosENCUESTA_2020.pdf (Consultado el 25 de julio de 2021).</Citation></Reference><Reference><Citation>Organizaci&#xf3;n Mundial de la Salud . Una definici&#xf3;n de caso cl&#xed;nico de afecci&#xf3;n pos-COVID-19 por el proceso de consenso Delphi 6 de octubre de 2021. Organizaci&#xf3;n Mundial de la Salud (2021). Available online at: https://apps.who.int/iris/handle/10665/349926</Citation></Reference><Reference><Citation>Subramanian A, Nirantharakumar K, Hughes S, Myles P, Williams T, Gokhale KM, et al. . S&#xed;ntomas y factores de riesgo de COVID prolongado en adultos no hospitalizados. Nat Med. (2022) 3:1&#x2013;9.</Citation></Reference><Reference><Citation>Raveendran A V, Jayadevan R, Sashidharan S. Long COVID: una visi&#xf3;n general. Diabetes Metab Syndr Clin Res Rev. (2021) 15:869&#x2013;75. 10.1016/j.dsx.2021.04.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dsx.2021.04.007</ArticleId><ArticleId IdType="pmc">PMC9637465</ArticleId><ArticleId IdType="pubmed">36351871</ArticleId></ArticleIdList></Reference><Reference><Citation>Aiyegbusi OL, Hughes SE, Turner G, Rivera SC, McMullan C, Chandan JS, et al. . S&#xed;ntomas, complicaciones y manejo de COVID largo: una revisi&#xf3;n. J R Soc Med. (2021) 114:428&#x2013;42. 10.1177/01410768211032850</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/01410768211032850</ArticleId><ArticleId IdType="pmc">PMC8450986</ArticleId><ArticleId IdType="pubmed">34265229</ArticleId></ArticleIdList></Reference><Reference><Citation>Grupo Asesor Cient&#xed;fico (Servicios de Salud de Alberta) . Revisi&#xf3;n actualizada de los s&#xed;ntomas prolongados despu&#xe9;s de una infecci&#xf3;n aguda por COVID-19. Updat Rev Prolong symptoms after acute COVID-19 Infect (2021). Available online at: https://www.albertahealthservices.ca/assets/info/ppih/if-ppih-covid-19-sag-chronic-symptoms-of-covid-rapid-review.pdf (Consultado el 25 de julio de 2021).</Citation></Reference><Reference><Citation>Ayoubkhani D, Khunti K, Nafilyan V, Maddox T, Humberstone B, Diamond I, et al. . S&#xed;ndrome post-covid en individuos ingresados en el hospital con covid-19: estudio de cohorte retrospectivo. BMJ. (2021) 372:693. 10.1136/bmj.n693</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n693</ArticleId><ArticleId IdType="pmc">PMC8010267</ArticleId><ArticleId IdType="pubmed">33789877</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobs LG, Gourna Paleoudis E, Lesky-Di Bari D, Nyirenda T, Friedman T, Gupta A, et al. . Persistencia de los s&#xed;ntomas y calidad de vida a los 35 d&#xed;as despu&#xe9;s de la hospitalizaci&#xf3;n por infecci&#xf3;n por COVID-19. PLoS Uno. (2020) 15:e0243882. 10.1371/journal.pone.0243882</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0243882</ArticleId><ArticleId IdType="pmc">PMC7732078</ArticleId><ArticleId IdType="pubmed">33306721</ArticleId></ArticleIdList></Reference><Reference><Citation>Iqbal FM, Lam K, Sounderajah V, Clarke JM, Ashrafian H, Darzi A. Caracter&#xed;sticas y predictores del s&#xed;ndrome post-COVID agudo y cr&#xf3;nico: Una revisi&#xf3;n sistem&#xe1;tica y metan&#xe1;lisis. EClinicalMedicine. (2021) 36:100899. 10.1016/j.eclinm.2021.100899</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.100899</ArticleId><ArticleId IdType="pmc">PMC8141371</ArticleId><ArticleId IdType="pubmed">34036253</ArticleId></ArticleIdList></Reference><Reference><Citation>Lund LC, Hallas J, Nielsen H, Koch A, Mogensen SH, Brun NC, et al. . Efectos postagudos de la infecci&#xf3;n por SARS-CoV-2 en individuos que no requieren ingreso hospitalario: un estudio de cohorte poblacional dan&#xe9;s. Lancet Infect Dis. (2021) 21:1373&#x2013;82. 10.1016/S1473-3099(21)00211-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00211-5</ArticleId><ArticleId IdType="pmc">PMC8110209</ArticleId><ArticleId IdType="pubmed">33984263</ArticleId></ArticleIdList></Reference><Reference><Citation>Mart&#xed;n-Guerrero JD, Florencio LL. Navarro-Pardo E, Rodr&#xed;guez-Jim&#xe9;nez J, Torres-Macho J, Pellicer-Valero OJ. &lt; jabb&gt;El an&#xe1;lisis de agrupamiento revela diferentes perfiles que asocian s&#xed;ntomas post-COVID a largo plazo, s&#xed;ntomas de COVID-19 al ingreso hospitalario y comorbilidades m&#xe9;dicas previas en sobrevivientes de COVID-19 previamente hospitalizados Infecci&#xf3;n. (2022) 1:1&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Carson G. Long Covid Forum Group. Research priorities for Long Covid: refined through an international multi-stakeholder forum. BMC Med. (2021) 19:84. 10.1186/s12916-021-01947-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-021-01947-0</ArticleId><ArticleId IdType="pmc">PMC8009733</ArticleId><ArticleId IdType="pubmed">33785027</ArticleId></ArticleIdList></Reference><Reference><Citation>Dom&#xed;nguez-Lara SA. El odds ratio y su interpretaci&#xf3;n como magnitud del efecto en investigaci&#xf3;n. Educ Med. (2018) 19:65&#x2013;6. 10.1016/j.edumed.2017.01.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.edumed.2017.01.008</ArticleId></ArticleIdList></Reference><Reference><Citation>Garc&#xed;a-Abell&#xe1;n J, Padilla S, Fern&#xe1;ndez-Gonz&#xe1;lez M, Garc&#xed;a JA, Agull&#xf3; V, Andreo M, et al. . Resultados cl&#xed;nicos, virol&#xf3;gicos e inmunol&#xf3;gicos a largo plazo en pacientes hospitalizados por COVID-19: la respuesta de anticuerpos predice covid largo. medRxiv. (2021).</Citation></Reference><Reference><Citation>Asadi-Pooya AA, Akbari A, Emami A, Lotfi M, Rostamihosseinkhani M, Nemati H, et al. . Risk factors associated with long COVID syndrome: a retrospective study. Ir&#xe1;n J Med Sci. (2021) 46:428&#x2013;36. 10.30476/ijms.2021.92080.2326</Citation><ArticleIdList><ArticleId IdType="doi">10.30476/ijms.2021.92080.2326</ArticleId><ArticleId IdType="pmc">PMC8611223</ArticleId><ArticleId IdType="pubmed">34840383</ArticleId></ArticleIdList></Reference><Reference><Citation>Boglione L, Meli G, Poletti F, Rostagno R, Moglia R, Cantone M, et al. . Factores de riesgo e incidencia del s&#xed;ndrome COVID largo en pacientes hospitalizados:? &#x2018;tiene el remdesivir un efecto protector? QJM An Int J Med. (2021) 114:865&#x2013;71. 10.1093/qjmed/hcab297</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/qjmed/hcab297</ArticleId><ArticleId IdType="pmc">PMC8690187</ArticleId><ArticleId IdType="pubmed">34850210</ArticleId></ArticleIdList></Reference><Reference><Citation>Peghin M, Palese A, Venturini M, De Martino M, Gerussi V, Graziano E, et al. . S&#xed;ntomas post-COVID-19 6 meses despu&#xe9;s de la infecci&#xf3;n aguda entre pacientes hospitalizados y no hospitalizados. Clin Microbiol Infect. (2021) 27:1507&#x2013;13. 10.1016/j.cmi.2021.05.033</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2021.05.033</ArticleId><ArticleId IdType="pmc">PMC8180450</ArticleId><ArticleId IdType="pubmed">34111579</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan Sui Ko A, Candellier A, Mercier M, Joseph C, Schmit JL, Lanoix JP, et al. . El n&#xfa;mero de s&#xed;ntomas iniciales est&#xe1; m&#xe1;s relacionado con la COVID-19 prolongada que con la gravedad aguda de la infecci&#xf3;n: una cohorte prospectiva de pacientes hospitalizados. Int J Infect Dis. (2022) 118:220&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8896858</ArticleId><ArticleId IdType="pubmed">35257903</ArticleId></ArticleIdList></Reference><Reference><Citation>Righi E, Mirandola M, Mazzaferri F, Dossi G, Razzaboni E, Zaffagnini A, et al. . Determinantes de la persistencia de los s&#xed;ntomas y el impacto en el bienestar f&#xed;sico y mental en Long COVID: a prospective cohort study. J Infect. (2022) 84:566&#x2013;72. 10.1016/j.jinf.2022.02.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2022.02.003</ArticleId><ArticleId IdType="pmc">PMC8828388</ArticleId><ArticleId IdType="pubmed">35150765</ArticleId></ArticleIdList></Reference><Reference><Citation>Taboada M, Rodr&#xed;guez N, D&#xed;az-Vieito M, Dom&#xed;nguez MJ, Casal A, Riveiro V, et al. . Calidad de vida y s&#xed;ntomas persistentes tras la hospitalizaci&#xf3;n por COVID-19. Estudio observacional prospectivo comparativo de pacientes con o sin ingreso en UCI. Rev Esp Anestesiol Reanim. (2022) 69:326&#x2013;35. 10.1016/j.redar.2021.05.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.redar.2021.05.009</ArticleId><ArticleId IdType="pmc">PMC8214168</ArticleId><ArticleId IdType="pubmed">34176973</ArticleId></ArticleIdList></Reference><Reference><Citation>Diputado Valverde Mateos, Gonz&#xe1;lez Romero A, Alvarado Ramos V, Miangolarra P&#xe1;gina JC. Evoluci&#xf3;n y calidad de vida a los tres meses de la hospitalizaci&#xf3;n por neumon&#xed;a por COVID. Rehabilitaci&#xf3;n. (2022) 1:11. 10.1016/j.rh.2021.11.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rh.2021.11.001</ArticleId><ArticleId IdType="pmc">PMC8758998</ArticleId><ArticleId IdType="pubmed">35039178</ArticleId></ArticleIdList></Reference><Reference><Citation>Rasulo FA, Piva S, Latronico N. Experts' Opinion complicaciones a largo plazo de coviD-19 en sobrevivientes de icU:? &#x2018;qu&#xe9; sabemos? (2021).</Citation></Reference><Reference><Citation>Mumtaz A, Sheikh AAE, Khan AM, Khalid SN, Khan J, Nasrullah A, et al. . COVID-19 vaccine and long covid: A scoping review. Life (Basel). (2022) 12:1066. 10.3390/life12071066</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/life12071066</ArticleId><ArticleId IdType="pmc">PMC9324565</ArticleId><ArticleId IdType="pubmed">35888154</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnold D, Milne A, Samms E, Stadon L, Maskell N, Hamilton F.? &#x2018;Son seguras las vacunas en pacientes con COVID largo? Un estudio observacional prospectivo. medRxiv. (2021). 10.1101/2021.03.11.21253225</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.03.11.21253225</ArticleId></ArticleIdList></Reference><Reference><Citation>Strain WD, Sherwood O, Banerjee A, Van der Togt V, Hishmeh L, Rossman J. El impacto de la vacunaci&#xf3;n contra covid en los s&#xed;ntomas de COVID largo: una encuesta internacional de personas con experiencia vivida de COVID prolongado. Vacunas. (2022) 10:652. 10.3390/vaccines10050652</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines10050652</ArticleId><ArticleId IdType="pmc">PMC9146071</ArticleId><ArticleId IdType="pubmed">35632408</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayoubkhani D, Bermingham C, Pouwels KB, Glickman M, Nafilyan V, Zaccardi F, et al. . Trayectoria de los s&#xed;ntomas largos de covid despu&#xe9;s de la vacunaci&#xf3;n contra covid-19: estudio de cohorte basado en la comunidad.</Citation></Reference><Reference><Citation>Raw RK, Kelly CA, Rees J, Wroe C, Chadwick DR. La infecci&#xf3;n previa por COVID-19, pero no la COVID prolongada, se asocia con un aumento de los eventos adversos despu&#xe9;s de la vacunaci&#xf3;n BNT162b2/Pfizer. J Infect. (2021) 83:381&#x2013;412. 10.1016/j.jinf.2021.05.035</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2021.05.035</ArticleId><ArticleId IdType="pmc">PMC8164507</ArticleId><ArticleId IdType="pubmed">34062184</ArticleId></ArticleIdList></Reference><Reference><Citation>Marco JJG, Pasqu&#xed;n MJ&#xc1;, Mart&#xed;n SM, Miranda APJ. Papel protector de las vacunas actuales para variantes del virus SARS-CoV-2 y COVID persistente. FMC - Formulario M&#xe9;dica Cont&#xed;n en Atenci&#xf3;n Primaria. (2022) 29:16&#x2013;25. 10.1016/j.fmc.2021.10.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.fmc.2021.10.001</ArticleId><ArticleId IdType="pmc">PMC8788134</ArticleId><ArticleId IdType="pubmed">35095266</ArticleId></ArticleIdList></Reference><Reference><Citation>Mishra PK, Bruiners N, Ukey R, Datta P, Onyuka A, Handler D, et al. . La vacunaci&#xf3;n aumenta las respuestas protectoras y contrarresta las c&#xe9;lulas B de memoria pat&#xf3;genas inducidas por el SARS-CoV-2. MedRxiv. (2021).</Citation></Reference><Reference><Citation>Taylor RR, Trivedi B, Patel N, Singh R, Ricketts WM, Elliott K, et al. . Post-COVID symptoms reported at asynchronous virtual review and stratified follow-up after COVID-19 pneumonia. Clin Med. (2021) 21:e384. 10.7861/clinmed.2021-0037</Citation><ArticleIdList><ArticleId IdType="doi">10.7861/clinmed.2021-0037</ArticleId><ArticleId IdType="pmc">PMC8313189</ArticleId><ArticleId IdType="pubmed">34103378</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>